The Centers for Medicare and Medicaid Services says it's reasonable and necessary for some Medicare beneficiaries to be covered for ambulatory blood pressure monitoring (APBM) for diagnostic and management purposes, and laid out its logic for doing so in a proposed decision memo released on April 9.
Under the proposed decision memo, ABPM devices could be used for beneficiaries with suspected white coat hypertension (high blood pressure in a clinical setting) and those with suspected masked...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?